(Q52847698)

English

Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins

scientific article published on October 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope Glycoproteins (English)

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

0 references

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

author name string

Neurath AR

1

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Jiang S

2

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Strick N

3

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Kolbe H

4

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Kieny MP

5

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Muchmore E

6

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Girard M

7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1720628

8 November 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/aid.1991.7.813

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

AIDS Research and Human Retroviruses

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

10

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

813-823

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

describes a project that uses

synthetic peptide

1 reference

based on heuristic

inferred from title

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

2

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

3

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

4

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

5

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

6

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals

7

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

B Cell Epitope Mapping of Human Immunodeficiency Virus Envelope Glycoproteins with Long (19- to 36-residue) Synthetic Peptides

8

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

9

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

13

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

14

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

15

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)

16

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

17

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

18

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

19

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine

20

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Studies on the immunogenicity of Chinese hamster ovary cell-derived recombinant gp120 (HIV-1IIIB).

21

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine.

22

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself

24

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

25

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

27

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

42 Two simple programs for the analysis of data from enzyme-linked immunosorbent assays (ELISA) on a programmable desk-top calculator

28

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Peptides Mimicking Selected Disulfide Loops in HIV-1 gp120, Other Than V3, Do Not Elicit Virus-Neutralizing Antibodies

29

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells

32

1 reference

10.1089/AID.1991.7.813

https://api.crossref.org/works/10.1089/AID.1991.7.813

8 November 2022

Identifiers

10.1089/AID.1991.7.813

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/1720628

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52847698&oldid=1878825368"